- Home
- CHGG vs RVNC Comparison
CHGG vs RVNC Comparison
Compare CHGG & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHGG
- RVNC
- Stock Information
- Founded
- CHGG 2005
- RVNC 1999
- Country
- CHGG United States
- RVNC United States
- Employees
- CHGG N/A
- RVNC N/A
- Industry
- CHGG Other Consumer Services
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- CHGG Real Estate
- RVNC Health Care
- Exchange
- CHGG Nasdaq
- RVNC Nasdaq
- Market Cap
- CHGG 169.0M
- RVNC 546.4M
- IPO Year
- CHGG 2013
- RVNC 2014
- Fundamental
- Price
- CHGG $1.52
- RVNC $5.28
- Analyst Decision
- CHGG Hold
- RVNC Buy
- Analyst Count
- CHGG 10
- RVNC 10
- Target Price
- CHGG $5.31
- RVNC $10.86
- AVG Volume (30 Days)
- CHGG 3.7M
- RVNC 1.8M
- Earning Date
- CHGG 11-12-2024
- RVNC 11-06-2024
- Dividend Yield
- CHGG N/A
- RVNC N/A
- EPS Growth
- CHGG N/A
- RVNC N/A
- EPS
- CHGG N/A
- RVNC N/A
- Revenue
- CHGG $683,338,000.00
- RVNC $251,178,000.00
- Revenue This Year
- CHGG N/A
- RVNC $20.36
- Revenue Next Year
- CHGG N/A
- RVNC $31.66
- P/E Ratio
- CHGG N/A
- RVNC N/A
- Revenue Growth
- CHGG N/A
- RVNC 40.23
- 52 Week Low
- CHGG $1.48
- RVNC $2.30
- 52 Week High
- CHGG $11.48
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- CHGG 39.09
- RVNC 43.99
- Support Level
- CHGG $1.50
- RVNC $5.10
- Resistance Level
- CHGG $1.63
- RVNC $5.43
- Average True Range (ATR)
- CHGG 0.11
- RVNC 0.17
- MACD
- CHGG 0.01
- RVNC 0.02
- Stochastic Oscillator
- CHGG 9.21
- RVNC 64.29
About CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.